Literature DB >> 33420125

Efficacy of compressed sodium chloride (CSC) against E. coli and Candida auris in minutes and methods improvement for testing.

Lan N Truong1,2, Brayden D Whitlock3,4.   

Abstract

Controlling infections has become one of the biggest problems in the world, whether measured in lives lost or money spent. This is worsening as pathogens continue becoming resistant to therapeutics. Antimicrobial surfaces are one strategy being investigated in an attempt to decrease the spread of infections through the most common route of transmission: surfaces, including hands. Regulators have chosen two hours as the time point at which efficacy should be measured. The objectives of this study were to characterize the new antimicrobial surface compressed sodium chloride (CSC) so that its action may be understood at timepoints more relevant to real-time infection control, under two minutes; to develop a sensitive method to test efficacy at short time points; and to investigate antifungal properties for the first time. E. coli and Candida auris are added to surfaces, and the surfaces are monitored by contact plate, or by washing into collection vats. An improved method of testing antimicrobial efficacy is reported. Antimicrobial CSC achieves at least 99.9% reduction of E. coli in the first two minutes of contact, and at least 99% reduction of C. auris in one minute.

Entities:  

Year:  2021        PMID: 33420125      PMCID: PMC7794526          DOI: 10.1038/s41598-020-79212-2

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  12 in total

Review 1.  Crisis in hospital-acquired, healthcare-associated infections.

Authors:  David P Calfee
Journal:  Annu Rev Med       Date:  2011-10-13       Impact factor: 13.739

2.  Use of copper cast alloys to control Escherichia coli O157 cross-contamination during food processing.

Authors:  J O Noyce; H Michels; C W Keevil
Journal:  Appl Environ Microbiol       Date:  2006-06       Impact factor: 4.792

3.  Underresourced hospital infection control and prevention programs: penny wise, pound foolish?

Authors:  Deverick J Anderson; Kathryn B Kirkland; Keith S Kaye; Paul A Thacker; Zeina A Kanafani; Grace Auten; Daniel J Sexton
Journal:  Infect Control Hosp Epidemiol       Date:  2007-05-31       Impact factor: 3.254

4.  Strategies to prevent healthcare-associated infections through hand hygiene.

Authors:  Katherine Ellingson; Janet P Haas; Allison E Aiello; Linda Kusek; Lisa L Maragakis; Russell N Olmsted; Eli Perencevich; Philip M Polgreen; Marin L Schweizer; Polly Trexler; Margaret VanAmringe; Deborah S Yokoe
Journal:  Infect Control Hosp Epidemiol       Date:  2014-09       Impact factor: 3.254

Review 5.  Controlling hospital-acquired infection: focus on the role of the environment and new technologies for decontamination.

Authors:  Stephanie J Dancer
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

6.  Compressed sodium chloride as a fast-acting antimicrobial surface: results of a pilot study.

Authors:  B D Whitlock; S W Smith
Journal:  J Hosp Infect       Date:  2016-05-06       Impact factor: 3.926

7.  The survival of Escherichia coli O157 on a range of metal surfaces.

Authors:  S A Wilks; H Michels; C W Keevil
Journal:  Int J Food Microbiol       Date:  2005-10-25       Impact factor: 5.277

8.  Estimating health care-associated infections and deaths in U.S. hospitals, 2002.

Authors:  R Monina Klevens; Jonathan R Edwards; Chesley L Richards; Teresa C Horan; Robert P Gaynes; Daniel A Pollock; Denise M Cardo
Journal:  Public Health Rep       Date:  2007 Mar-Apr       Impact factor: 2.792

Review 9.  Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe.

Authors:  M Goto; M N Al-Hasan
Journal:  Clin Microbiol Infect       Date:  2013-03-08       Impact factor: 8.067

10.  Universal and reusable virus deactivation system for respiratory protection.

Authors:  Fu-Shi Quan; Ilaria Rubino; Su-Hwa Lee; Brendan Koch; Hyo-Jick Choi
Journal:  Sci Rep       Date:  2017-01-04       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.